New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

National Healthcare Properties, Inc.

NHP

Real Estate Reit Healthcare Facilities

National Healthcare Properties, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $342.3 million, down 3.25% from fiscal 2024.

Revenue
+19.8%
EPS
n/m
Free cash flow
n/m
Total debt
+79.0%

Quarter to September 2026, against a year earlier

14.82 0.31 +2.14%

After hours trading: 14.82, unchanged, last trade Fri 4:01pm Eastern.

Market cap
$985.7M
P/E
n/m
Fwd P/E FY26e
16.2×
Dividend yield
1.01%
F-score
5/9
ROIC
1.83%
Net debt / EBITDA
6.4×
Payout ratio
—

Where the cash went Twelve months to Sep 30, 2026

Free cash flow was −$132.1M: capital expenditures were more than operating cash flow. Cash rose by $41.5M. Lines the picture does not name came to −$15.3M. What is a cash flow statement?

Free cash flow
−$132.1M −234.5% of operating cash flow
Returned to shareholders
$19.4M
Debt, net
−$172.0M repaid
Change in cash
+$41.5M over the period
Where the cash went, in millions of dollars
Operating cash flow56.3
Capital expenditures−188.4
Free cash flow−132.1
Into investments, net−4.4
Dividends−19.4
Shares issued, net+384.7
Debt repaid, net−172.0
Other−15.3
Change in cash41.5
Operating cash flowCapexFree cash flow
Operating cash flow, capex and free cash flow, four quarters
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Operating cash flow$7M$37M$51M$56M
Capex$71M−$12M−$114M−$188M
Free cash flow$78M$25M−$63M−$132M

Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.

Older periods Dec '25 Mar '26 Jun '26 Sep '26
Net Income

+8 more TTM periods

(57.68) (60.45) (45.00) (12.23)
Depreciation & Amortization
84.56 74.83 72.17 77.22
Non Cash Items (Other)
25.70 38.25 29.58 (6.76)
Accounts Receivable Change
(2.04) (3.67) (2.81) (1.69)
Change in payables and accrued liability
(41.22) (6.34) (3.89) (1.89)
Change in other assets and liabilities
(2.36) (5.42) 0.71 1.66
Operating Cash Flow
6.95 37.19 50.75 56.31
Capital expenditures
71.19 (12.12) (113.60) (188.39)
Short Term Investments Change (Net)
(1.64) (1.53) (1.53) (4.39)
Investing cash flow
69.81 (13.66) (115.13) (192.78)
Repayment/Issuance of Debt (Net)
(14.33) (14.99) (178.64) (171.95)
Equity Repurchase (Common, Net)
(1.55) — 497.86 495.61
Equity Repurchase (Preffered, Net)
(5.42) — (31.03) (111.54)
Dividends Paid (Total)
(13.63) (13.47) (13.38) (19.43)
Other financial activities
(8.04) (8.48) (13.54) (18.07)
Financing cash flow
(42.40) (43.35) 263.59 177.96
Change in Cash
34.36 (19.81) 199.21 41.50
Beginning Cash
74.10 108.45 108.45 108.45
Ending Cash
108.45 88.64 307.66 149.95
Stock Based Compensation
3.77 4.38 5.42 6.22
Dividends Paid (Common)
(0.18) (0.18) (0.18) (5.72)
Assets Liabilities Change (Total)
(45.62) (15.43) (6.00) (1.92)
Investments Change (Net)
(1.64) (1.53) (1.53) (4.39)
Dividends Paid (Preffered)
(13.44) (13.29) (13.20) (13.72)
Issuance/Purchase of Shares
(6.40) — 467.41 384.65

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026